Figure 4.
Identification of HER2 overexpression subtype (ER-, HER2+). Sections of feline mammary adenocarcinoma with tubular and papillary (A) and solid morphology were estrogen receptor negative (B) and HER2 positive (C), but focally positive for CK5/6 (D).